Controversies in the management of clinical stage I seminoma: Carboplatin a decade in - Time to start backing out Journal Article


Authors: van de Wetering, R. A. W.; Sleijfer, S.; Feldman, D. R.; Funt, S. A.; Bosl, G. J.; de Wit, R.
Article Title: Controversies in the management of clinical stage I seminoma: Carboplatin a decade in - Time to start backing out
Keywords: cancer recurrence; drug efficacy; risk benefit analysis; note; cancer adjuvant therapy; follow up; cancer incidence; carboplatin; metastasis; tumor volume; patient monitoring; cancer therapy; risk factor; high risk patient; cardiovascular disease; lymph node; second cancer; adjuvant radiotherapy; disease specific survival; seminoma; intermediate risk patient; adverse event; low risk patient; human; priority journal; standardized mortality ratio; rete testis
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 9
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-03-20
Start Page: 837
End Page: 840
Language: English
DOI: 10.1200/jco.2017.76.5610
PROVIDER: scopus
PUBMED: 29389229
PMCID: PMC6804842
DOI/URL:
Notes: Note -- Export Date: 1 May 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Darren Richard Feldman
    340 Feldman
  2. George Bosl
    430 Bosl
  3. Samuel Aaron Funt
    135 Funt